By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Company News
BioTime (BTX)’s Subsidiary OncoCyte Corporation Files Form 10 Registration Statement For Planned Distribution 10/8/2015 11:53:12 AM
BioTime (BTX) Announces The Closing Of A $20 Million Direct Registered Offering; Demand Exceeds NIS 80 Million Offered 10/2/2015 10:26:15 AM
BioTime (BTX) Agrees To Sell $5.1 Million Of Equity 10/2/2015 10:20:14 AM
Heraeus Medical GmbH And BioTime (BTX) Subsidiary Orthocyte Corporation Enter Into Exclusive Worldwide Development And Licensing Agreements 9/30/2015 11:48:55 AM
BioTime (BTX) Agrees to Sell Up To $20.7 Million Of Common Shares 9/28/2015 2:03:32 PM
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Ltd. Receives FDA Fast-Track Designation For Opregen For The Treatment Of The Dry Form Of Age-Related Macular Degeneration 9/28/2015 12:51:33 PM
BioTime (BTX) Agrees To Sell $8.58 Million Of Common Shares 9/14/2015 3:21:13 PM
BioTime (BTX) Subsidiary OncoCyte Corporation Appoints Cavan Redmond To Its Board Of Directors 9/14/2015 12:20:56 PM
BioTime (BTX) Announces Dual Listing On The Tel Aviv Stock Exchange 9/4/2015 7:51:49 AM
ESI BIO - A Division Of BioTime (BTX) Launches New Research Technology Platform, Vascunet Pericyte Co-Culture Assay 9/2/2015 10:55:24 AM